Viomi Technology Co., Ltd

Hello, ladies and gentlemen. Thank you for standing by for Viomi Technology Co. Ltd's earnings conference call for the second half and full year of 2025. At this time, all participants are in listen-only mode. Today's conference call is being recorded. I will now turn the call over to your host, Ms. Clare Gee, the IR Director of the company. Please go ahead, Clare.

Hello, everyone, and welcome to Wellme Technology Company Limited's earnings conference call for the second half and the full year of 2025. As a reminder, this conference is being recorded. The company's financial and operating and posted online. You can download the earnings press release and sign up for the company's email distribution list by visiting the IR section of the company's website at ir.biomi.com. Participating in today's call are Mr. Xiaoping Chen, the founder chairman of the board of directors and the chief executive officer, and Sam Yang, the head of our capital and investment department. The company's management will begin with prepared remarks and the call will conclude with a Q&A session. Before we continue, please note that the company's discussion will contain forward-looking statements made under the safe harbor provisions of the U.S. Private Security Litigation Reform Act of 1995. Forward-looking statements involve inherent risks and uncertainties. As such, the company's actual results may be materially different from the views expressed today. Further information regarding this and other risks and uncertainties is included in the company's annual report on the Form 20 Act and other filings assailed with U.S. Securities and Exchange Commission. The company does not assume any obligation to update any forward-looking statements except as required by law. Please also note that well-meant earnings press release and this conference call include discussions on an automated gap financial information as well as and audited non-GAAP financial measures. In addition, Valmy's price release contains a recommendation of an under-audited non-GAAP measure to an audited most directly comparable GAAP measure. I'll now turn the call over to our funder, Mr. Xiaoping Chen. Mr. Chen will deliver his remarks in Chinese, forward immediately by English translation. Mr. Chen, please go ahead.

Hello, everyone. Thank you for joining us in the second half of the year and the first quarter of the year. In the second half of the year in 2025, with China's public persuasion and the company's strategic investment in the development and construction of new products and brands overseas, we achieved a sales income of 9.5 billion yuan, and a gross profit of about 21.25 million yuan. From the whole year, the core business base is still stable. Last year, we achieved a total sales income of 24.3 billion yuan, China China China China The demand for diversified users leads to technical breakthroughs. With AI technology, users can bring better product experience, and become the world's leading water supply technology company. In the North American market, the performance of our Amazon channel is outstanding. In the second half of last year, it made a three-digit growth in return. In the black five, the 19th place in the water supply list, and in the bottom five, the fourth place. The high-end flagship mineral water purifier, Master One, has also further announced product development. In the Southeast Asian market, we are working with the main channels in Malaysia to achieve strategic cooperation and continue to evolve. In the field of local localization, we are launching a small-scale, large-scale, and smart-functional Inno mining power panel machine. In terms of brand construction, we have invited famous actors and singers from different countries to serve as brand directors, attend online press conferences, and enter the Jishui Super Factory to purchase the brand image of technology health. In April of this year, we will introduce a new brand image, a high-end brand image, . . . . . Europe, Southeast Asia, and other overseas markets to provide consistent supply chain support. By the end of 2025, the global patent will break through 1,950, with a total of 14 countries and regions. In the field of AI intelligent computing, macroeconomic precision regulation, and intelligent innovation, we will build a systematic technical foundation for global business expansion and solid foundation. In terms of shareholder feedback, we announced a special share of $0.88 per share in July 2025. In October of this year, the company received a return of $20 million in shares in the first round. By December 31, 2025, a total of 1.03 million shares were bought back, a total of about $2.5 million. In the recent performance announcement, we have further announced that we will send $0.066 of special shares to each ADS and a total of about $31 million of RMB shares. Thank you for your long-term trust and support. We use the common growth of the real estate and shareholders to provide long-term value to the public. In 2026, we will carry out the strategic goals of Global Water more firmly, and achieve breakthroughs in the following four aspects. The first is to focus on overseas, deepen the strategic market, and expand to more countries and regions, rely on the rapid advantage of water-intensive factories, and continue to introduce cultural new products, and increase the influence of brands to more markets. The second is to stick to the difference-making route, The country continues to strengthen the health and mental health of the Kunlun series, to technologically diversify and product innovation, foster quality improvement, and enhance Yunmei's industry position in the technology market. Third, Jada AI and technology deep integration, let technology innovation become the core mission of the company's transition cycle and continuous growth. Fourth, deepening cooperation, continue deepening cooperation with strategic partners in the field, to release Jada AI and technology deepening cooperation, to release Jada AI and technology deepening cooperation, to release Jada AI Thank you, Mr. Chen.